2Regar E, Serruys PW, Bode C, et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Veloc- ity Balloon-Expandable Stent(RAVEL) : sirolimus-eluting stents in- hibit restenosis irrespective of the vessel size [ J ]. Circulation ,2002, 106 ( 15 ) : 1949 -1956. 被引量：1
3West NE, Ruyrok PN, Disco CM, et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients [ J ]. Circulation,2004,109 ( 7 ) : 867 -873. 被引量：1
4Meredith IT, Ormiston J, Whitbourn R,et al. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial [ J ]. Euro Intervention,2005,1 (2) : 157-164. 被引量：1
5Umeda H, Kawai T, Misumida N, et al. Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes [ J ]. Circ Cardiovasc In- terv,2011,4(4) :349-354. 被引量：1
6Suttorp Mj,I'man GJ,Rahel BM ,et al. Pirmary Stenting of Totally Occluded Native Coronary Arteries lI ( PRISON II ) : a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions [ J ]. Circulation, 2006,114 ( 9 ) : 921-992. 被引量：1
7Giannakakou P,Roby R,Fojo T,et al. Low concentration of peclitaxel induce cell type dependent p53,p21 and G1,G2 arrest in stead of mitotic arrest: molecular determinants of paclitaxel induced cytotoxicity[J]. Oncogene,2001,20:3806-3813. 被引量：1
